Preferential 8q24 Allelic Imbalance and MYC gene Copy Number in Primary Prostate Cancer

[1]  Esko Ukkonen,et al.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling , 2009, Nature Genetics.

[2]  A. Skol,et al.  Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. , 2009, Carcinogenesis.

[3]  Kenneth Offit,et al.  A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms , 2009, Nature Genetics.

[4]  Tony Fletcher,et al.  Sequence variant on 8q24 confers susceptibility to urinary bladder cancer , 2008, Nature Genetics.

[5]  Jun Luo,et al.  Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis , 2008, Modern Pathology.

[6]  Jianfeng Xu,et al.  Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. , 2008, Neoplasia.

[7]  John L Hopper,et al.  Multiple loci with different cancer specificities within the 8q24 gene desert. , 2008, Journal of the National Cancer Institute.

[8]  Pär Stattin,et al.  Cumulative association of five genetic variants with prostate cancer. , 2008, The New England journal of medicine.

[9]  E. Cook,et al.  Relationship of EGFR Mutations, Expression, Amplification, and Polymorphisms to Epidermal Growth Factor Receptor Inhibitors in the NCI60 Cell Lines , 2007, Clinical Cancer Research.

[10]  J. Carpten,et al.  Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. , 2007, Genome research.

[11]  J. Brooks,et al.  Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. , 2007, Cancer research.

[12]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[13]  Steven Gallinger,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.

[14]  R. Henrique,et al.  Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. , 2007, European urology.

[15]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.

[16]  J. Witte.  Multiple prostate cancer risk variants on 8q24 , 2007, Nature Genetics.

[17]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[18]  J. Cerhan,et al.  Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. , 2007, Cancer research.

[19]  A. Whittemore,et al.  Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.

[20]  A. Gylfason,et al.  A common variant associated with prostate cancer in European and African populations , 2006, Nature Genetics.

[21]  P. Bugert,et al.  c‐MYC Asn11Ser is associated with increased risk for familial breast cancer , 2005, International journal of cancer.

[22]  Hongtao Yu,et al.  Human MMS21/NSE2 Is a SUMO Ligase Required for DNA Repair , 2005, Molecular and Cellular Biology.

[23]  Silvia Benvenuti,et al.  Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. , 2005, The Lancet. Oncology.

[24]  D. Bostwick,et al.  Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[25]  D. Bostwick,et al.  Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. , 1997, Cancer research.

[26]  L. Aaltonen,et al.  Semiautomated assessment of loss of heterozygosity and replication error in tumors. , 1996, Cancer research.

[27]  Sampsa Hautaniemi,et al.  Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. , 2008, Cancer research.

[28]  Paul Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft , 2007 .